Cell-based passive immunization for protection against SARS-CoV-2 infection.

Evan SawulaShane MierschEric D JongChengjin LiFang-Yu ChouJean Kit TangReza SaberianfarJeffrey HardingSachdev S SidhuAndras Nagy

Published in: Stem cell research & therapy (2023)

Together, these findings show the promise and potential of using 'off-the-shelf' cell products that secrete neutralizing antibodies for sustained protective immunity against current and future viral pathogens of public health significance.

Keyphrases

public health
single cell
cell therapy
sars cov
stem cells
machine learning
risk assessment
big data
respiratory syndrome coronavirus
dengue virus
gram negative
human health
artificial intelligence
coronavirus disease